The DOI matches its Crossref record; 496 of the 496 references it cites were found in a registry or an index.
Toxicity of amphetamines: an update
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 496
TOXICITY AND CATECHOLAMINE RELEASING ACTIONS OF d- AND l-AMPHETAMINE IN ISOLATED AND AGGREGATED MICE
Moore, K. E. (1963) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26632-0 · Cited by 121
Review article: Amphetamines and related drugs of abuse
Greene, S. L., Kerr, F., & Braitberg, G. (2008) · Emergency Medicine Australasia · doi:10.1111/j.1742-6723.2008.01114.x · Cited by 121
Harrington, R. D., Woodward, J. A., Hooton, T. M., & Horn, J. R. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.18.2221 · Cited by 121
Analysis of Methamphetamine in Hair, Nail, Sweat, and Saliva by Mass Fragmentography
Suzuki, S., Inoue, T., Hori, H., & Inayama, S. (1989) · Journal of Analytical Toxicology · doi:10.1093/jat/13.3.176 · Cited by 118
Lim, H. K., & Foltz, R. L. (1988) · Chemical Research in Toxicology · doi:10.1021/tx00006a008 · Cited by 117
Chemical Analysis of Ecstasy Pills
Baggott, M. J., Heifets, B. D., Jones, R. T., Mendelson, J., Sferios, E., & Zehnder, J. (2000) · JAMA · doi:10.1001/jama.284.17.2190 · Cited by 116
Pedersen, N. P., & Blessing, W. W. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08648.2001 · Cited by 116
Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans.
Cook, C. E., Jeffcoat, A. R., Sadler, B. M., Hill, J. M., Voyksner, R. D., Pugh, D. E., White, W. R., & Perez‐Reyes, M. (1992) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08806-3 · Cited by 115
Sprague, J. E., & Nichols, D. E. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09490-x · Cited by 115
Cardiomyopathy associated with amphetamine administration
Smith, H., Roche, A., Jagusch, M. F., & Herdson, P. B. (1976) · American Heart Journal · doi:10.1016/s0002-8703(76)80545-5 · Cited by 114
Fuller, R. W., & Hemrick-Luecke, S. K. (1980) · Science · doi:10.1126/science.7384808 · Cited by 114
Death following ingestion of MDMA (ecstasy) and moclobemide
Vuori, E., Henry, J. A., Ojanperä, I. A., Nieminen, R., Savolainen, T., Wahlsten, P., & Jäntti, M. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00292.x · Cited by 114
Tancer, M., & Johanson, C.-E. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0576-z · Cited by 113
THE PHARMACOLOGY AND TOXICOLOGY OF POLYPHENOLIC-GLUTATHIONE CONJUGATES
Monks, T. J., & Lau, S. S. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.229 · Cited by 112
Imam, S. Z., Newport, G. D., Itzhak, Y., Cadet, J. L., Islam, F., Slikker, W., & Ali, S. F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00029.x · Cited by 111
Sanchez, V., Camarero, J., Esteban, B. M., Peter, M. J., Green, A. R., & Colado, M. I. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704230 · Cited by 111
Healthy nightclubs and recreational substance use
Bellis, M. A., Hughes, K. E., & Lowey, H. (2002) · Addictive Behaviors · doi:10.1016/s0306-4603(02)00271-x · Cited by 110
Fetal Effects of Psychoactive Drugs
Salisbury, A. L., Ponder, K. L., Padbury, J. F., & Lester, B. M. (2009) · Clinics in Perinatology · doi:10.1016/j.clp.2009.06.002 · Cited by 110
Farfel, G. M., & Seiden, L. S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24411-1 · Cited by 110
Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH
Wan, S. H., Matin, S. B., & Azarnoff, D. L. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978235585 · Cited by 110
Acute myocardial infarction resulting from amphetamine abuse: A spasm-thrombus interplay?
Bashour, T. T. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90757-9 · Cited by 109
Bai, F., Lau, S. S., & Monks, T. J. (1999) · Chemical Research in Toxicology · doi:10.1021/tx990084t · Cited by 109
Farfel, G. M., & Seiden, L. S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24505-0 · Cited by 108
Shankaran, M., Yamamoto, B. K., & Gudelsky, G. A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00728-1 · Cited by 106
Kuypers, K. P. C., Samyn, N., & Ramaekers, J. G. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0434-z · Cited by 106
Neurotoxicity mechanisms of thioether ecstasy metabolites
Capela, J. P., Macedo, C., Branco, P. S., Ferreira, L. M., Lobo, A. M., Fernandes, E. G. R., Remião, F., Bastos, M. D. L., Dirnagl, U., Meisel, A., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.028 · Cited by 106
Self-citationEcstasy-fueled 'rave' parties become dances of death for English youths
Randall, T. (1992) · JAMA · doi:10.1001/jama.268.12.1505 · Cited by 105
Naltrexone Attenuates the Subjective Effects of Amphetamine in Patients with Amphetamine Dependence
Jayaram‐Lindström, N., Konstenius, M., Eksborg, S., Beck, O., Hammarberg, A., & Franck, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301572 · Cited by 105
Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review
Grunau, B. E., Wiens, M. O., & Brubacher, J. R. (2010) · Canadian Journal of Emergency Medicine · doi:10.1017/s1481803500012598 · Cited by 104
Segura, M., Ortuño, J., Farré, M., McLure, J. A., Pujadas, M., Pizarro, N., Llebaria, A., Joglar, J., Roset, P. N., Segura, J., et al. (2001) · Chemical Research in Toxicology · doi:10.1021/tx010051p · Cited by 104
Methamphetamine‐induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite
Brown, J. M., Quinton, M. S., & Yamamoto, B. K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03379.x · Cited by 103
Reay, J. L., Hamilton, C., Kennedy, D. O., & Scholey, A. B. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063269 · Cited by 103
Sitte, H. H., & Freissmuth, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06474.x · Cited by 103
Sandoval, V., Riddle, E. L., Hanson, G. R., & Fleckenstein, A. E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045005 · Cited by 103
Walubo, A., & Seger, D. (1999) · Human & Experimental Toxicology · doi:10.1177/096032719901800209 · Cited by 102
Fast uptake and long-lasting binding of methamphetamine in the human brain: Comparison with cocaine
Fowler, J. S., Volkow, N. D., Logan, J., Alexoff, D. L., Telang, F., Wang, G., Wong, C., Ma, Y., Kriplani, A., Pradhan, K., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.07.020 · Cited by 102
Oyler, J. M., Cone, E. J., Joseph, R. E., et al. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.10.1703 · Cited by 102
Capela, J. P., Ruscher, K., Lautenschlager, M., Freyer, D., Dirnagl, U., Gaio, R., Bastos, M. D. L., Meisel, A., & Carvalho, F. D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.007 · Cited by 101
Self-citationCauses and Consequences of Methamphetamine and MDMA Toxicity
Quinton, M. S., & Yamamoto, B. K. (2006) · The AAPS Journal · doi:10.1208/aapsj080238 · Cited by 99
Jiménez, A., Jordà, E. G., Verdaguer, E., Pubill, D., Sureda, F. X., Canudas, A. M., Escubedo, E., Camarasa, J., Camins, A., & Pallàs, M. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.017 · Cited by 98
Schmued, L. C. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02563-0 · Cited by 98
Pharmacological content of tablets sold as “ecstasy”: Results from an online testing service
Tanner‐Smith, E. E. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.11.016 · Cited by 98
Mills, E., Rusyniak, D. E., & Sprague, J. E. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0591-7 · Cited by 97
Acute renal failure after ecstasy.
Fahal, I. H., Sallomi, D., Yaqoob, M., & Bell, G. M. (1992) · BMJ · doi:10.1136/bmj.305.6844.29 · Cited by 96
Lorez, H. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90053-9 · Cited by 96
MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE
Heydari, A., Yeo, K. R., Lennard, M. S., Ellis, S. W., Tucker, G. T., & Rostami‐Hodjegan, A. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001180 · Cited by 96
Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users
Dafters, R. I., Hoshi, R., & Talbot, A. C. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1561-4 · Cited by 96
Ketamine in Non-Hospital and Hospital Deaths in New York City
Gill, J. R., & Stajić, M. (2000) · Journal of Forensic Sciences · doi:10.1520/jfs14742j · Cited by 95
Sprague, J. E., Banks, M. L., Cook, V. J., & Mills, E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044982 · Cited by 95
Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users
de Win, M. M. L., Jager, G., Booij, J., Reneman, L., Schilt, T., Lavini, C., Olabarriaga, S. D., den Heeten, G. J., & van den Brink, W. (2008) · Brain · doi:10.1093/brain/awn255 · Cited by 94
Zalis, E. G., & PARMLEY, L. F. (1963) · Archives of Internal Medicine · doi:10.1001/archinte.1963.03860060060004 · Cited by 93
Cadet, J. L., Ladenheim, B., Baum, I., Carlson, E. J., & Epstein, C. J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91624-1 · Cited by 93
Miller, R. T., Lau, S. S., & Monks, T. J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00044-7 · Cited by 93
Blessing, W. W., & Seaman, B. W. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00810-2 · Cited by 93
Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions
Samyn, N., Boeck, G. D., Wood, M., Lamers, C. T. J., de Waard, D., Brookhuis, K., Verstraete, A., & Riedel, W. J. (2002) · Forensic Science International · doi:10.1016/s0379-0738(02)00157-3 · Cited by 93
Bastos, M. D. L., Carvalho, M. X. E. R., Milhazes, N., Remião, F., Borges, F., Fernandes, E. G. R., Amado, F. M. L., Monks, T. J., & Carvalho, F. D. (2004) · Archives of Toxicology · doi:10.1007/s00204-003-0510-7 · Cited by 92
Self-citationGHB and synthetic cathinones: clinical effects and potential consequences
Karila, L., & Reynaud, M. (2010) · Drug Testing and Analysis · doi:10.1002/dta.210 · Cited by 92
Docherty, J. R., & Green, A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00722.x · Cited by 91
The Complications of 'Ecstasy' (MDMA)
Alrazi, J. (1988) · JAMA · doi:10.1001/jama.1988.03720110019021 · Cited by 91
Impact of psychostimulants on vesicular monoamine transporter function
Fleckenstein, A. E., & Hanson, G. R. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.077 · Cited by 91
Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits
Jeng, W., Wong, A. W., Ting‐A‐Kee, R. A., & Wells, P. G. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.015 · Cited by 91
Ramamoorthy, Y., Tyndale, R. F., & Sellers, E. M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200108000-00003 · Cited by 91
Thompson, M. R., Li, K. M., Clemens, K. J., Gurtman, C. G., Hunt, G. E., Cornish, J. L., & McGregor, I. S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300347 · Cited by 89
Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA
Yang, J., Jamei, M., Heydari, A., Yeo, K. R., de la Torre, R., Farré, M., Tucker, G. T., & Rostami‐Hodjegan, A. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106065907 · Cited by 88
Multiple toxicity from 3,4-methylenedioxymethamphetamine (“ecstasy”)
Greene, S. L., Dargan, P. I., O’Connor, N., Jones, A. L., & Kerins, M. (2003) · The American Journal of Emergency Medicine · doi:10.1053/ajem.2003.50028 · Cited by 88
Preston, K. L., Wagner, G. C., Schuster, C. R., & Seiden, L. S. (1985) · Brain Research · doi:10.1016/0006-8993(85)90153-2 · Cited by 87
Ecstasy induces apoptosis via 5-HT2A-receptor stimulation in cortical neurons
Capela, J. P., Fernandes, E. G. R., Remião, F., Bastos, M. D. L., Meisel, A., & Carvalho, F. D. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.04.005 · Cited by 87
Self-citationMDMA and temperature: A review of the thermal effects of ‘Ecstasy’ in humans
Parrott, A. C. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.08.012 · Cited by 87
Effect of diet and nutrition on the expression of cytochromes P450
Ioannides, C. (1999) · Xenobiotica · doi:10.1080/004982599238704 · Cited by 87
Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines
Xie, T., Tong, L., McLane, M. W., Hatzidimitriou, G., Yuan, J., McCann, U. D., & Ricaurte, G. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301031 · Cited by 86
Safety of ephedra: lessons learned
Soni, M. G., Carabin, I. G., Griffiths, J. C., & Burdock, G. A. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.07.006 · Cited by 86
Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Adolescent Rat Brain Mitochondria
Alves, E., Summavielle, T., Alves, C. J., GOMES‐DA‐SILVA, J., Barata, J. C., Fernandes, E. G. R., Bastos, M. D. L., Ferreira, M. A., & Carvalho, F. D. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2645-07.2007 · Cited by 86
Self-citationNeurotoxicity of Ecstasy Metabolites in Rat Cortical Neurons, and Influence of Hyperthermia
Capela, J. P., Meisel, A., Abreu, A. R., Branco, P. S., Ferreira, L. M., Lobo, A. M., Remião, F., Bastos, M. L., & Carvalho, F. D. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092577 · Cited by 85
Self-citationEffects of Naltrexone on the Subjective Response to Amphetamine in Healthy Volunteers
Jayaram‐Lindström, N., Wennberg, P., Hurd, Y. L., & Franck, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000144893.29987.e5 · Cited by 85
Jones, A. W. (2005) · Traffic Injury Prevention · doi:10.1080/15389580500253760 · Cited by 85
Pharmacogenetic Treatments for Drug Addiction: Cocaine, Amphetamine and Methamphetamine
Haile, C. N., Kosten, T. R., & Kosten, T. A. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990902825447 · Cited by 85
Pacifici, R., Zuccaro, P., LÓPEZ, C. H., Pichini, S., Carlo, S. D., Farré, M., Roset, P. N., Ortuño, J., Segura, J., & de la Torre, R. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29682-8 · Cited by 85
Segura, M., Farr, M., Pichini, S., Peir, A. M., Roset, P. N., rez, A. R., Ortu�o, J., Pacifici, R., Zuccaro, P., Segura, J., et al. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544060-00006 · Cited by 84
Vollenweider, F. X., Maguire, R. P., Leenders, K. L., Mathys, K., & Angst, J. (1998) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(98)00033-x · Cited by 83 · cited 7×
“Neuroimaging techniques, like PET, were used in combination with a 5-HTT ligand in human ''ecstasy'' users, showing lower density of brain 5-HTT sites (McCann et al. 1998, 2005, 2008).”
BackgroundMethodInfluentialBlessing, W. W., Seaman, B. W., Pedersen, N. P., & Ootsuka, Y. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06385.2003 · Cited by 83
Krasnova, I. N., Ladenheim, B., & Cadet, J. L. (2005) · The FASEB Journal · doi:10.1096/fj.04-2881fje · Cited by 83
“Ecstasy” and Sudden Cardiac Death
Suarez, R. V., & Riemersma, R. (1988) · American Journal of Forensic Medicine & Pathology · doi:10.1097/00000433-198812000-00015 · Cited by 83
Reversible dilated cardiomyopathy induced by methamphetamine
Jacobs, L. J. (1989) · Clinical Cardiology · doi:10.1002/clc.4960121211 · Cited by 83
Ito, H., Yeo, K. K., Wijetunga, M., Seto, T. B., Tay, K., & Schatz, I. J. (2009) · Clinical Cardiology · doi:10.1002/clc.20367 · Cited by 83
Toxin-Induced Hyperthermic Syndromes
Rusyniak, D. E., & Sprague, J. E. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2005.06.002 · Cited by 83
Carvalho, M. X. E. R., HAWKSWORTH, G. M., Milhazes, N., Borges, F., Monks, T. J., Fernandes, E. G. R., Carvalho, F. X. E. L., & Bastos, M. D. L. (2002) · Archives of Toxicology · doi:10.1007/s00204-002-0381-3 · Cited by 82
Self-citationAzmitia, E. C., Murphy, R. B., & Whitaker‐Azmitia, P. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)90732-q · Cited by 81
Clemens, K. J., van Nieuwenhuyzen, P. S., Li, K. M., Cornish, J. L., Hunt, G. E., & McGregor, I. S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1786-x · Cited by 81
Carvalho, M. C., Remião, F., Milhazes, N., Borges, F., Fernandes, E. G. R., Carvalho, F. D., & Bastos, M. D. L. (2004) · Toxicology · doi:10.1016/j.tox.2004.03.016 · Cited by 81
Self-citationRoiser, J. P., Cook, L. J., Cooper, J. D., Rubinsztein, D. C., & Sahakian, B. J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.609 · Cited by 81
Dopamine-Induced Behavioral Changes and Oxidative Stress in Methamphetamine-Induced Neurotoxicity
Kita, T., Miyazaki, I., Asanuma, M., Takeshima, M., & Wagner, G. C. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)88003-3 · Cited by 80
Sprague, J. E., Moze, P., Caden, D., Rusyniak, D. E., Holmes, C. S., Goldstein, D. S., & Mills, E. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000165969.29002.70 · Cited by 80
Acute Myocardial Infarction Associated With Amphetamine Use
Waksman, J. C., Taylor, R. N., Bodor, G. S., Daly, F. F. S., Jolliff, H. A., & Dart, R. C. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.3.323 · Cited by 80
Costa, V. M., Silva, R. V. D. S., Ferreira, L. M., Branco, P. S., Carvalho, F. D., Bastos, M. D. L., Carvalho, R. A., Carvalho, M. C., & Remião, F. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7000916 · Cited by 79
Self-citationMechanisms of MDMA (Ecstasy)-Induced Oxidative Stress, Mitochondrial Dysfunction, and Organ Damage
Song, B., Moon, K., Upreti, V. V., Eddington, N. D., & Lee, I. J. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110791591436 · Cited by 79
Melega, W. P., Jorgensen, M. J., Laćan, G., Way, B. M., Pham, J., Morton, G. G., Cho, A. K., & Fairbanks, L. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301502 · Cited by 79
Pu, C., Fisher, J. E., Cappon, G. D., et al. (1994) · Brain Research · doi:10.1016/0006-8993(94)91067-7 · Cited by 78
Metabolism Is Required for the Expression of Ecstasy-Induced Cardiotoxicity in Vitro
Carvalho, M. C., Remião, F., Milhazes, N., Borges, F., Fernandes, E. G. R., Monteiro, M. D. C., Gonçalves, M. J., Seabra, V., Amado, F. M. L., Carvalho, F. D., et al. (2004) · Chemical Research in Toxicology · doi:10.1021/tx049960f · Cited by 78
Self-citationScreening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases
Thull, U., & Testa, B. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90271-2 · Cited by 77
Differences in club drug use between heterosexual and lesbian/bisexual females
Parsons, J. T., Kelly, B. C., & Wells, B. E. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2006.03.006 · Cited by 77
Clinical Effects of Daily Methamphetamine Administration
Perez‐Reyes, M., White, W. R., McDonald, S. A., Hicks, R. E., Jeffcoat, A. R., Hill, J. M., & Cook, C. E. (1991) · Clinical Neuropharmacology · doi:10.1097/00002826-199108000-00007 · Cited by 77
Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction
Lord, K. C., Shenouda, S. K., McIlwain, E., Charalampidis, D., Lucchesi, P. A., & Varner, K. J. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq043 · Cited by 77
Mechanism of vasopressin-induced platelet aggregation
Filep, J. G., & Rosenkranz, B. (1987) · Thrombosis Research · doi:10.1016/0049-3848(87)90252-0 · Cited by 76
Kim, I., Oyler, J. M., Moolchan, E. T., Cone, E. J., & Huestis, M. A. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200412000-00013 · Cited by 76
Stone, D. M., Johnson, M., Hanson, G. R., & Gibb, J. W. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90173-7 · Cited by 75
A Single Methamphetamine Administration Rapidly Decreases Vesicular Dopamine Uptake
Brown, J. M., Riddle, E. L., Sandoval, V., Weston, R. K., Hanson, J. E., Crosby, M. J., Ugarte, Y. V., Gibb, J. W., Hanson, G. R., & Fleckenstein, A. E. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.2.497 · Cited by 75
Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose
García-Repetto, R., Moreno, E., Soriano, T., Jurado, C., Giménez, M. P., & Menéndez‐González, M. (2003) · Forensic Science International · doi:10.1016/s0379-0738(03)00179-8 · Cited by 74
Cardiovascular Responses Elicited by the “Binge” Administration of Methamphetamine
Varner, K. J., Ogden, B. A., Delcarpio, J. B., & Meleg-Smith, S. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.152 · Cited by 74
THE PATHOPHYSIOLOGY OF ACUTE AMPHETAMINE POISONING WITH PATHOLOGIC CORRELATION
Zalis, E. G., Lundberg, G. D., & Knutson, R. A. (1967) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27769-2 · Cited by 74
Implications of pharmacogenetics for individualizing drug treatment and for study design
Meisel, C., Gerloff, T., Kirchheiner, J., Mrozikiewicz, P. M., Niewiński, P., Brockmöller, J., & Roots, I. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0417-4 · Cited by 73
Bach, M., Coutts, R. T., & Baker, G. B. (1999) · Xenobiotica · doi:10.1080/004982599238344 · Cited by 73
Montiel‐Duarte, C., Ansorena, E., López-Zabalza, M. J., et al. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.020 · Cited by 73
Badon, L. A., Hicks, A. R., Lord, K. C., Ogden, B. A., Meleg-Smith, S., & Varner, K. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.3.898 · Cited by 73
Elevated environmental temperature and methamphetamine neurotoxicity
Miller, D. B., & O'Callaghan, J. P. (2003) · Environmental Research · doi:10.1016/s0013-9351(02)00051-8 · Cited by 72
Parrott, A. C., Milani, R. M., Gouzoulis‐Mayfrank, E., & Daumann, J. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0715-7 · Cited by 72
Long-Term Cardiovascular Effects of Mixed Amphetamine Salts Extended Release in Adults With ADHD
Weisler, R. H., Biederman, J., Spencer, T. J., & Wilens, T. E. (2005) · CNS Spectrums · doi:10.1017/s109285290000242x · Cited by 71
Carvalho, M. C., Carvalho, F. D., Remião, F., Pereira, M. D. L., das Neves, R. P., & Bastos, M. D. L. (2002) · Archives of Toxicology · doi:10.1007/s00204-002-0324-z · Cited by 71
Self-citationPizarro, N., Farré, M., Pujadas, M., Peiró, A. M., Roset, P. N., Joglar, J., & de la Torre, R. (2004) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)02984-2 · Cited by 71
Sprague, J. E., Yang, X., Sommers, J., Gilman, T. L., & Mills, E. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107755 · Cited by 70
Safety of intravenous methamphetamine administration during treatment with bupropion
Newton, T. F., Roache, J. D., Garza, R. D. L., Fong, T., Wallace, C. L., Li, S.-H., Elkashef, A. M., Chiang, N., & Kahn, R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0102-8 · Cited by 69
Pro‐oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes
Barbosa, D. J., Capela, J. P., Oliveira, J. M. A., Silva, R. V. D. S., Ferreira, L. M., Siopa, F., Branco, P. S., Fernandes, E. G. R., Duarte, J. A., Bastos, M. D. L., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01453.x · Cited by 68
Self-citationEscobedo, I., O’Shea, E., Orío, L., Sánchez, V., Segura, M., de la Torre, R., Farré, M., Green, A. R., & Colado, M. I. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706071 · Cited by 68
Quinone Electrophiles Selectively Adduct “Electrophile Binding Motifs” within Cytochrome c
Fisher, A. A., Labenski, M., Malladi, S., Gokhale, V. M., Bowen, M. E., Milleron, R. S., Bratton, S. B., Monks, T. J., & Lau, S. S. (2007) · Biochemistry · doi:10.1021/bi700613w · Cited by 68
Lin, L. Y., Kumagai, Y., & Cho, A. K. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00027a013 · Cited by 67
Nisijima, K., Shioda, K., Yoshino, T., Takano, K., & Kato, S. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(02)00213-9 · Cited by 67
Hall, W., & Hando, J. (1994) · Drug and Alcohol Review · doi:10.1080/09595239400185371 · Cited by 67
Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions
Yu, A. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9028-5 · Cited by 67
Ramamoorthy, Y., Yu, A., Suh, N., Haining, R. L., Tyndale, R. F., & Sellers, E. M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01028-6 · Cited by 66
MONITORING SYNTHETIC DRUG MARKETS, TRENDS, AND PUBLIC HEALTH
Spruit, I. P. (2001) · Substance Use & Misuse · doi:10.1081/ja-100000227 · Cited by 66
GREER, G., & Strassman, R. J. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1391 · Cited by 65
Ischemic stroke after using over the counter products containing ephedra
Chen, C., Biller, J., Willing, S. J., & Lopez-Yunez, A. M. (2003) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.08.012 · Cited by 65
Antagonism of cocaine, amphetamine, and methamphetamine toxicity
Derlet, R. W., Albertson, T. E., & Rice, P. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90071-o · Cited by 65
Makisumi, T., Yoshida, K.-I., Watanabe, T., Tan, N., Murakami, N., & Morimoto, A. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00758-4 · Cited by 65
Bexis, S., & Docherty, J. R. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706688 · Cited by 64
Inhibition of monoamine oxidase by d-methamphetamine
Suzuki, O., Hattori, H., Asano, M., Oya, M., & Katsumata, Y. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90493-1 · Cited by 64
McNamara, R., Kerans, A., O’Neill, B. V., & Harkin, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.08.006 · Cited by 64
Clemens, K. J., McGregor, I. S., Hunt, G. E., & Cornish, J. L. (2007) · Drug and Alcohol Review · doi:10.1080/09595230601036945 · Cited by 64
Amphetamines and Related Stimulants: Chemical, Biological, Clinical, and Sociological Aspects
(2019) · CRC Press eBooks · doi:10.1201/9780429279843 · Cited by 62
Moon, K., Upreti, V. V., Yu, L., Lee, I. J., Ye, X., Eddington, N. D., Veenstra, T. D., & Song, B. (2008) · PROTEOMICS · doi:10.1002/pmic.200800215 · Cited by 62
Miller, R. T., Lau, S. S., & Monks, T. J. (1996) · Chemical Research in Toxicology · doi:10.1021/tx9501546 · Cited by 62
Corcoran, G. B., & Wong, B. K. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00230-7 · Cited by 62
Mechanisms Underlying the Hepatotoxic Effects of Ecstasy
Carvalho, M. C., Pontes, H., Remião, F., Bastos, M. D. L., & Carvalho, F. D. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110791591535 · Cited by 61
Self-citationEcstasy: Pharmacodynamic and Pharmacokinetic Interactions
Oesterheld, J. R., Armstrong, S. C., & Cozza, K. L. (2004) · Psychosomatics · doi:10.1176/appi.psy.45.1.84 · Cited by 61
Wiley, J. L., Evans, R. L., Grainger, D. B., & Nicholson, K. L. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00077.x · Cited by 60
Johnson, M., Letter, A. A., Merchant, K., Hanson, G. R., & Gibb, J. W. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24573-6 · Cited by 60
Fowler, J. S., Kroll, C., Ferrieri, R. A., Alexoff, D. L., Logan, J., Dewey, S. L., Schiffer, W. K., Schlyer, D. J., Carter, P. M., King, P., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.040279 · Cited by 59
Morley, K. C., Li, K. M., Hunt, G. E., Mallet, P. E., & McGregor, I. S. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.002 · Cited by 59
Movahed, M., & Mostafizi, K. (2008) · Echocardiography · doi:10.1111/j.1540-8175.2007.00604.x · Cited by 59
Amphetamine induces hydroxyl radical formation in the striatum of rats
Huang, N., Wan, F.-J., Tseng, C., & Tung, C. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00924-7 · Cited by 58
Bingham, C. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.10.2654 · Cited by 58
Cardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHD
Winterstein, A. G., Gerhard, T., Shuster, J., & Saidi, A. (2009) · Pediatrics · doi:10.1542/peds.2008-3138 · Cited by 56
Drug use and risk behaviour among regular ecstasy users: Does sexuality make a difference?
Degenhardt, L. J. (2005) · Culture Health & Sexuality · doi:10.1080/13691050500349875 · Cited by 56
de la Torre, R., Ortuño, J., Más, M., Farré, M., & Segura, J. (1999) · The Lancet · doi:10.1016/s0140-6736(05)75653-1 · Cited by 55
Letter, E. A. D., Bouche, M.-P. L. A., Bocxlaer, J. F. V., Lambert, W. E., & Piette, M. H. A. (2004) · Forensic Science International · doi:10.1016/j.forsciint.2003.12.015 · Cited by 55
Zhao, Z., Castagnoli, N. J., Ricaurte, G. A., Steele, T., & Martello, M. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00025a015 · Cited by 55
SELECTIVE (+)‐AMPHETAMINE NEUROTOXICITY ON STRIATAL DOPAMINE NERVE TERMINALS IN THE MOUSE
Jonsson, G., & Nwanze, E. A. C. (1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb09303.x · Cited by 55
A Case of Mao Inhibitor/MDMA Interaction: Agony After Ecstasy
Smilkstein, M. J., Smolinske, S. C., & Rumack, B. H. (1987) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563658708992620 · Cited by 54
Blood coagulation and fibrinolysis in heat stroke
Mustafa, K. Y., Omer, O., Khogali, M., Jamjoom, A. A., Gumaa, K. A., El‐Nasr, N. A., & Gader, M. A. (1985) · British Journal of Haematology · doi:10.1111/j.1365-2141.1985.tb02856.x · Cited by 54
Cardiovascular and sympathetic responses and reflex changes elicited by MDMA
O'Cain, P., Hletko, S. B., Ogden, B. A., & Varner, K. J. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00235-3 · Cited by 54
Amphetamines as Potential Inducers of Fatalities: A review in the district of Ghent from 1976-2004
Letter, E. A. D., Piette, M. H. A., Lambert, W. E., & Cordonnier, J. A. C. M. (2006) · Medicine Science and the Law · doi:10.1258/rsmmsl.46.1.37 · Cited by 53
Cerretani, D., Riezzo, I., Fiaschi, A. I., Centini, F., Giorgi, G., D’Errico, S., Fiore, C., Karch, S. B., Neri, M., Pomara, C., et al. (2008) · International Journal of Legal Medicine · doi:10.1007/s00414-008-0262-2 · Cited by 53
Carvalho, F. D., Remião, F., Soares, M. E., Catarino, R. I. L., Queiróz, G., & Bastos, M. D. L. (1997) · Archives of Toxicology · doi:10.1007/s002040050407 · Cited by 52
Self-citationChronopharmacokinetics and Chronopharmacodynamics of Dextromethamphetamine in Man
Shappell, S. A., Kearns, G. L., Valentine, J. L., Neri, D. F., & DeJohn, C. A. (1996) · The Journal of Clinical Pharmacology · doi:10.1177/009127009603601109 · Cited by 52
Gollamudi, R., Sf, A., Lipe, G. W., Newport, G. D., Webb, P. J., López, M. D. G., Leakey, J. E. A., Kolta, M. G., & Slikker, W. (1989) · PubMed · Cited by 52
Ecstasy and the concomitant use of pharmaceuticals
Copeland, J., Dillon, P., & Gascoigne, M. B. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.05.025 · Cited by 51
Delaforge, M., Jaouen, M., & Bouillé, G. (1999) · Environmental Toxicology and Pharmacology · doi:10.1016/s1382-6689(99)00007-1 · Cited by 51
Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine (‘Ecstasy’) cytotoxicity
Carmo, H., Brulport, M., Hermes, M., Oesch, F., Silva, R. V. D. S., Ferreira, L. M., Branco, P. S., de Boer, D., Remião, F., Carvalho, F. D., et al. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230419.05221.fc · Cited by 50
Self-citationStereoselective pharmacokinetics of 3,4‐methylenedioxymethamphetamine in the rat
Fitzgerald, R. L., Blanke, R. V., & Poklis, A. (1990) · Chirality · doi:10.1002/chir.530020409 · Cited by 50
Nakagawa, Y., Suzuki, T., Tayama, S., Ishii, H., & Ogata, A. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0323-9 · Cited by 50
Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain
Izco, M., Orío, L., O’Shea, E., & Colado, M. I. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0602-1 · Cited by 50
Brain concentrations of d-MDMA are increased after stress
Johnson, E. A., O'Callaghan, J. P., & Miller, D. B. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1740-3 · Cited by 50
Hohoff, C., McDonald, J. M., Baune, B. T., Cook, E. H., Deckert, J., & de Wit, H. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30228 · Cited by 50
Neurotoxic effects of MDMA (“ecstasy”) administration to neonatal rats
Meyer, J. S., Grande, M., Johnson, K. M., & Ali, S. F. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.04.007 · Cited by 49
Methylenedioxymethamphetamine (ecstasy)-related hyperthermia
Patel, M. M., Belson, M. G., Longwater, A. B., Olson, K. R., & Miller, M. A. (2005) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2005.05.007 · Cited by 49
3,4-Methylenedioxymethamphetamine (“Ecstasy”) induces apoptosis of cultured rat liver cells
Montiel‐Duarte, C., Varela‐Rey, M., Osés-Prieto, J. A., López-Zabalza, M. J., Beitia, G., Cenarruzabeitia, E., & Iraburu, M. J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00112-6 · Cited by 49
Fletcher, P. J., Robinson, S. R., & Slippoy, D. L. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00222-6 · Cited by 49
Warren, M. W., Larner, S. F., Kobeissy, F. H., Brezing, C., Jeung, J. A., Hayes, R. L., Gold, M. S., & Wang, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0259-9 · Cited by 48
Johnson, E. A., O'Callaghan, J. P., & Miller, D. B. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02310-7 · Cited by 48
Potentiation of cocaine and d-amphetamine toxicity with caffeine
Derlet, R. W., Tseng, J. C., & Albertson, T. E. (1992) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(92)90211-f · Cited by 48
Wichems, C. H., Hollingsworth, C. K., & Bennett, B. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00774-k · Cited by 48
Nishiyama, T., Ikeda, M., Iwata, N., Suzuki, T., Kitajima, T., Yamanouchi, Y., Sekine, Y., Iyo, M., Harano, M., Komiyama, T., et al. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500292 · Cited by 48
Hashimoto, T., Hashimoto, K., Matsuzawa, D., Shimizu, E., Sekine, Y., Inada, T., Ozaki, N., Iwata, N., Harano, M., Komiyama, T., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30164 · Cited by 48
Further evidence of association between amphetamine response and SLC6A2 gene variants
Dlugos, A. M., Hamidovic, A., Palmer, A. A., & de Wit, H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1628-y · Cited by 48
Kurling, S., Kankaanpää, A., & Seppαlä, T. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.12.021 · Cited by 47
Ecstasy‐induced toxicity in rat liver
Beitia, G., Cobreros, A., Sainz, L., et al. (2000) · Liver International · doi:10.1034/j.1600-0676.2000.020001008.x · Cited by 47
Leith, N. J., & Barrett, R. J. (1981) · Psychopharmacology · doi:10.1007/bf00431751 · Cited by 47
Deaths involving serotonergic drugs
Pilgrim, J. L., Gerostamoulos, D., & Drummer, O. H. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.01.014 · Cited by 47
Fatal Amphetamine-Associated Cardiotoxicity and Its Medicolegal Implications
Jacobs, W. (2006) · American Journal of Forensic Medicine & Pathology · doi:10.1097/01.paf.0000188082.68009.10 · Cited by 46
Pontes, H., Duarte, J. A., de Pinho, P. G., Soares, M. E., Fernandes, E. G. R., Dinis‐Oliveira, R. J., Sousa, C., Silva, R., Carmo, H., Casal, S. I. P., et al. (2008) · Toxicology · doi:10.1016/j.tox.2008.07.064 · Cited by 46
Self-citationOotsuka, Y., Nalivaiko, E., & Blessing, W. W. (2004) · Brain Research · doi:10.1016/j.brainres.2004.03.058 · Cited by 46
Garbino, J., Henry, J. A., Mentha, G., & Romand, J. A. (2001) · Clinical cornerstone · doi:10.1016/s1098-3597(01)90081-x · Cited by 46
Serotonin toxicity involving MDMA (ecstasy) and moclobemide
Pilgrim, J. L., Gerostamoulos, D., Woodford, N. W. F., & Drummer, O. H. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.04.008 · Cited by 45
Garcia‐Ratés, S., Camarasa, J., Escubedo, E., & Pubill, D. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.05.015 · Cited by 45
Behavioural and neurochemical effects of combined MDMA and THC administration in mice
Robledo, P., Trigo, J. M., Panayi, F., de la Torre, R., & Maldonado, R. J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0879-8 · Cited by 45
Vascular actions of MDMA involve α1 and α2‐adrenoceptors in the anaesthetized rat
McDaid, J., & Docherty, J. R. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704094 · Cited by 45
Huben, S. N. V., Lay, C. C., Crean, R. D., Davis, S. A., Katner, S. N., & Taffe, M. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301078 · Cited by 45
Flanagin, B. A., Cook, E. H., & de Wit, H. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30327 · Cited by 44
FitzGerald, J., & Reid, J. J. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03738.x · Cited by 44
Ide, S., Kobayashi, H., Ujike, H., Ozaki, N., Sekine, Y., Inada, T., Harano, M., Komiyama, T., Yamada, M., Iyo, M., et al. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500355 · Cited by 43
Meyer, A., Mayerhofer, A., Kovar, K., & Schmidt, W. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00821-2 · Cited by 43
Cited by
Khat and synthetic cathinones: a review
Valente, M. J., Guedes de Pinho, P., de Lourdes Bastos, M., Carvalho, F., & Carvalho, M. (2014) · Archives of Toxicology · doi:10.1007/s00204-013-1163-9 · Cited by 337
Self-citationComprehensive review of cardiovascular toxicity of drugs and related agents
Mladěnka, P., Applová, L., Patočka, J., Costa, V. M., Remiao, F., Pourová, J., Mladěnka, A., Karlíčková, J., Jahodář, L., Vopršalová, M., et al. (2018) · Medicinal Research Reviews · doi:10.1002/med.21476 · Cited by 310
Self-citationDesigner drugs: mechanism of action and adverse effects
Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Ceceli, A. O., Bradberry, C. W., & Goldstein, R. Z. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01153-9 · Cited by 150
Metadata
- Authors
- Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M. D. L.
- Venue
- Archives of Toxicology
- Published
- 2012-03-06
- Volume
- 86
- Issue
- 8
- Pages
- 1167-1231
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W1971191340
- Cited by
- 431
- References
- 496
- FWCI
- 48.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.